0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Paradigm Medical Industries
Its shares trade under the ticker PDMI. It has been listed since 22 July 1996.
Paradigm Medical Industries, Inc. is a medical device manufacturing company, which engages in design, development and sale of technology diagnostic eye care instruments and related products for early detection of glaucoma and other eye disorders. The company is headquartered in Salt Lake City, Utah. The firm markets its products to ophthalmologists, optometrists, universities, hospitals and clinics. The Company’s products include A-Scans, A/B Scans, Blood Flow Analyzer, Pachymeter, Field Perimeter, Corneal Topographers, Ocular Electrophysiology, UBMS, Endothelial camera and accessories. The P-2700 is a combination of A-Scan and B-Scan. Paradigm’s Blood Flow Analyzer (BFA) is a tonometer that offers measurement of Ocular Blood flow (OBF). The PARAVUE 300 Corneal Topographer is used in diagnostic and contact lens applications. Paramax provides the detection of glaucoma through its objective 90 second long PERG test. The P60 UBM is the Ultrasound Bio Microscope and provides unprecedented image accuracy. The PARACAM 1000 is a non-contact endothelial microscope.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 22 Jul 1996
- Employees
- 5
- Website
- Paradigm-Medical.com ↗
Leadership
Pay as last reported
- Mr. Jim HudakChairman of the Board, since 2017
- Stephen DavisPresident, Treasurer$20,402
- Mr. John WattsChief Executive Officer, Director, since 2017
- Mr. Keith IgnotzDirector
- John PingreeDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Paradigm Medical Industries Inc has a strong reputation in the medical industry with a track record of high-quality products and reliable customer service. The company's skilled workforce and experienced management team contribute to its overall strength. Additionally, Paradigm Medical Industries Inc operates efficient production processes, resulting in cost-effective operations and competitive pricing.
Weaknesses
- Although Paradigm Medical Industries Inc enjoys a solid reputation, the company faces certain weaknesses. These include a relatively small market share compared to some of its competitors and limited geographic presence. Additionally, there may be a dependency on a few key customers, which poses a risk if any of these customers reduce their business or switch suppliers.
Opportunities
- Several opportunities exist for Paradigm Medical Industries Inc. Firstly, advancements in technology and healthcare create a favorable environment for the development of innovative medical products. Moreover, the increasing aging population and rising healthcare expenditures present a growing market for medical devices and equipment. The company can also explore strategic partnerships or acquisitions to expand its market reach and diversify its product portfolio.
Threats
- Paradigm Medical Industries Inc faces various threats that could impact its business. Intense competition within the medical industry poses a significant challenge, with competitors vying for market share. Additionally, stringent regulatory requirements and compliance standards add complexity and costs to product development and manufacturing processes. Economic downturns and fluctuations in healthcare policies could also affect customer demand and purchasing power.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.